Moderator
Emma Sceats
Chief Executive Officer, CN Bio Innovations Ltd. |
 Keynote Speakers
James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos | 
Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT) | 
Reyk Horland
Head of Business Development, TissUse GmbH | 
Kristin Fabre
Microphysiological Systems Lead, Drug Safety & Metabolism, AstraZeneca | 
Katia Karalis
Executive Vice President of Research, Emulate, Inc. | 
Michael Shuler
Samuel B. Eckert Professor of Engineering, Cornell University, President & CEO, Hesperos, Inc. |
|
Olivier Guenat
Head, Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research, University of Bern-Switzerland | 
Daniel Irimia
Associate Director, BioMEMS Resource Center, Harvard Medical School | 
Noo Li Jeon
Professor, Seoul National University | 
Tommy Andersson
Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, AstraZeneca, Gothenburg | 
John Wikswo
Gordon A. Cain University Professor, A.B. Learned Professor of Living State Physics; Founding Director, Vanderbilt Institute for Integrative Biosystems, Vanderbilt University | 
Linda Griffith
Professor, Massachusetts Institute of Technology (MIT) | 
Dan Huh
Assistant Professor and Wilf Family Term Endowed Chair, University of Pennsylvania | 
George Truskey
R. Eugene and Susie E. Goodson Professor of Biomedical Engineering, Duke University | 
Ali Khademhosseini
Professor, Department of Medicine, Brigham and Women’s Hospital; Wyss Institute for Biologically Inspired Engineering, Harvard University |
OverviewSelect Biosciences Third Annual Organ-on-a-Chip World Congress 2017 focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner. These clusters of "assembled cells" have functional significance and can mimic in vivo organ structure. Liver cells assembled on-board chips in a physiologically-relevant architecture using microfluidics can, for instance, be utilized for toxicity screening and the ability to assemble organ fragments ex vivo can provide an exquisite means to reconstruct biological processes (both physiological and pathological) "in a dish" or "on a chip." A number of chips such Lung-on-a-Chip, Brain-on-a-Chip, Gut-on-a-Chip, Marrow-on-a-Chip, Bone-on-a-Chip, Nerve-on-a-Chip amongst others have been built and will be presented and explored at this conference. We will also focus on "disease-on-a-chip", cancer-on-a-chip, immune system-on-a-chip. Due to the Overlap of this Topic with 3D-Culture and Stem Cells in Drug Discovery, the co-located concurrent parallel conference tracks focus on these topics thereby offering complete coverage of these related fields to the conference delegates. The Three Conference Tracks are Co-Located and Concurrent and Delegates can Participate, Mix-and-Match Presentations and Network Extensively with their Colleagues from all 3 Conference Tracks. The Exhibit hall is also co-located and accessible by delegates from all three conference tracks. Co-Located, Concurrent Conference Tracks:
- Organ-on-a-Chip World Congress 2017
- 3D-Culture 2017
- Stem Cells in Drug Discovery & Toxicity Screening 2017
All the Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.
Agenda and Information for:
|
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2017-07-10 00:00:002017-07-11 00:00:00Europe/LondonOrgan-on-a-Chip World Congress and 3D-Culture 2017Organ-on-a-Chip World Congress and 3D-Culture 2017 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
